Seeking Alpha5h agoAlphabet: Funding Scare Bolsters Bull CaseAlphabet reported third-quarter revenue up 25% to $127.6 billion. Google Cloud rose 103%, with backlog at $560 billion. The company raised about $147 billion over nine months while free cash flow was negative.5h ago
The Economic Times6h agoGold tops Rs 1.35 lakh per 10g, silver adds Rs 1,460/kg after steep slide on Fed rate-hike betsSpot gold held at $3,856.52 an ounce after earlier sliding to its lowest level since October last year. CME data put the odds of a 25-basis-point Federal Reserve rate hike in December at nearly 97%.6h ago
The Economic Times6h agoBlackRock India ETF Draws $316 Million in Largest Weekly Inflow Since June 2025BlackRock's India-focused ETF booked its largest weekly inflow since June 2025. AI-related volatility pushed money away from technology-heavy markets. The iShares MSCI Taiwan ETF drew record redemptions, while the iShares MSCI South Korea ETF saw large-scale outflows.6h ago
The Straits Times6h agoAnthropic IPO puts future AI valuation in focusAnthropic, the developer of Claude, plans to go public. It is targeting a market capitalization of up to US$1.4 trillion. The company intends to raise US$90 billion through the offering.6h ago
Livemint7h agoGold prices near 1-year low, silver slides as dollar hits 19-month highA stronger dollar and rising expectations for a 25-basis-point Federal Reserve rate hike in December are weighing on gold prices. Market pricing puts the probability of that move at 96.6%.7h ago
CNBC TV187h agoWill Gold prices reclaim record highs? Goldman Sachs says it will take two yearsGoldman Sachs analysts led by Lina Thomas wrote that it expects further weakness and heightened volatility in the near-term for Gold prices as the Federal Reserve continues to tighten monetary policy, hurting the yellow metal in the process, as it does not yield any interest.7h ago
Nine.com.au7h agoAustralia's TGA approves daily weight-loss pills, including Wegovy and oral GLP1sThe TGA has approved Eli Lilly's Foundayo and Novo Nordisk's Wegovy tablets. Both require a prescription, and monthly costs are about $250 to $395.7h ago
MarketScreener7h agoIndian shares on track for muted start as global cues weakenNov 17 - Indian shares are likely to open little changed on Tuesday, pausing after a November rally in the benchmark indexes driven by record foreign inflows and resilient corporate earnings. The GIFT...7h ago